Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107 Claritas Pharmaceuticals, Inc.April 21, 2021 GMT SAN FRANCISCO and TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into an agreement with CMAX Clinical Research Pty Ltd (“CMAX”) to conduct a randomized, placebo-controlled, single-blind, single ascending dose Phase 1 clin...